Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 2/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | KCNN4 | O15554 | 4/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28867951 | 0.75 | AR (0.39) | ARPGRKCNN4CYP1A2CYP3A4 | |
| SCHEMBL7633389 | 0.73 | AR (0.36) | ARPGRKCNN4 | |
| SCHEMBL554230 | 0.73 | KCNN4 (0.37) | KCNN4 | |
| SCHEMBL28671391 | 0.72 | AR (0.35) | ARPGRKCNN4CYP1A2CYP3A4 | |
| SCHEMBL780814 | 0.69 | ACHE (0.36) | ARPGRKCNN4CYP1A2CYP3A4 | |
| SCHEMBL30966621 | 0.69 | ACHE (0.36) | ARPGRKCNN4CYP1A2CYP3A4 | |
| SCHEMBL2391883 | 0.68 | KCNN4 (0.46) | ARPGRKCNN4CYP1A2CYP3A4 | |
| SCHEMBL2974402 | 0.68 | KCNN4 (0.39) | KCNN4 | |
| SCHEMBL9281500 | 0.68 | KCNN4 (0.39) | KCNN4 | |
| SCHEMBL2525080 | 0.68 | KCNN4 (0.44) | KCNN4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6392083-B2 | REACTING A CYANOBENZYLAMINE WITH AN ACID SELECTED FROM HYDROCHLORIC ACID, SULFURIC ACID, ACETIC ACID, TRIFLUROACETIC ACID AND PROPIONIC ACID TO FORM A SALT HAVING HIGH BULK DENSITY | SHOWA DENKO K.K. (JP) | 2002-05-21 | — | — | US | disclosed |
| US-20010049453-A1 | Process for producing salts of cyanobenzylamines | SHOWA DENKO K.K. | 2001-12-06 | — | — | US | disclosed |
| EP-1151989-A1 | PROCESS FOR PRODUCING SALT OF CYANOBENZYLAMINE OR DERIVATIVE | Showa Denko K.K. (JP) | 2001-11-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010049453-A1 | Process for producing salts of cyanobenzylamines | MMAB, BLVRB, SLC6A12 | AR 4574/4885PGR 4753/4885KCNN4 338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.